1
|
Mouhoub B, Bensalah M, Berhili A, Azghar A, El Malki J, El Mezgueldi I, Nassiri O, Slaoui M, Miri A, Rochdi C, Benajiba N, Seddik R. Visceral leishmaniasis associated with macrophage activation syndrome: Case report and literature review. IDCases 2021; 26:e01247. [PMID: 34430207 PMCID: PMC8371194 DOI: 10.1016/j.idcr.2021.e01247] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 08/06/2021] [Accepted: 08/06/2021] [Indexed: 11/24/2022] Open
Abstract
Background The combination of visceral leishmaniasis (VL) and macrophage activation syndrome (MAS) makes the diagnosis difficult due to their similar clinical presentation, with a poor prognosis especially since the treatment is still poorly codified. We report the case of a 17-month-old female patient from Berkane, presenting for a 3 months history of anarchic fever with anemic syndrome made up of pallor and hemorrhagic syndrome made up of epistaxis. Physical examination revealed a temperature of 39 ° C, lower limbsedema, paleness of skin and mucous membranes, gingival petechiae, bleached hair, and hepatosplenomegaly. Case presentation The complete blood count showed pancytopenia with deep aregenerative normochromic normocytic anemia at 3 g/dL, leukocytes were at 4860/mm 3 with neutropenia at 680/mm 3 and thrombocytopenia at 12.000/mm3, the blood smear was without abnormality. These anomalies were associated with a hypoalbunemia, hypertriglyceridemia, hyperferritinemia, lactate dehydrogenase (LDH) level was at 337 IU/L, low prothrombin time (PT) at 56 % and fibrinogen level at 1 g/L. The direct Coombs test was positive. Examination of the myelogram revealed the presence of leishmania bodies and figures of hemophagocytosis. A diagnosis of visceral leishmaniasis associated with MAS was made. The patient was put on liposomal amphotericin B and corticosteroid therapy with good clinical and biological evolution and good therapeutic tolerance. Conclusion The association of VL and MAS remains rare and should be evoked even in non-endemic areas since late diagnosis worsens the prognosis and may even be responsible for the death of patients despite an aggressive treatment.
Collapse
Affiliation(s)
- Boutaina Mouhoub
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Mohammed Bensalah
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Abdelilah Berhili
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco
| | - Ali Azghar
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Jalila El Malki
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Imane El Mezgueldi
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Oumaima Nassiri
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Mounia Slaoui
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco
| | - Achraf Miri
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| | - Chaymae Rochdi
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco
| | - Noufissa Benajiba
- Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco.,Pediatric Service, University Hospital Center Mohamed VI Oujda, Morocco
| | - Rachid Seddik
- Central Laboratory, University Hospital Center Mohamed VI Oujda, Morocco.,Faculty of Medicine and Pharmacy Oujda, Mohammed First University Oujda, Morocco
| |
Collapse
|